ICAD INC. - COMMON STOCK

iCAD to Report First Quarter 2021 Financial Results on Wednesday, April 28

20 4 2021 16:01:00 提供 Nasdaq GlobeNewswire

New Research Confirms iCAD’s ProFound AI Aids Breast Cancer Detection with Digital Breast Tomosynthesis, Improves Radiologists’ Workflow

19 4 2021 08:00:01 提供 Nasdaq GlobeNewswire

iCAD Announces Estimated Q1 Revenues and Upcoming CFO Transition

05 4 2021 16:01:00 提供 Nasdaq GlobeNewswire

New Research Indicates ProFound AI May Reduce Interval Breast Cancer Rates

31 3 2021 08:00:01 提供 Nasdaq GlobeNewswire

iCAD Announces FDA Clearance for ProFound AI Version 3.0 for 3D Mammography

15 3 2021 18:04:42 提供 Nasdaq GlobeNewswire

New Research Supporting ProFound AI Presented at European Congress of Radiology Online Meeting

08 3 2021 12:36:23 提供 Nasdaq GlobeNewswire

iCAD to Participate in the Cowen 41st Annual Health Care Conference

03 3 2021 21:16:22 提供 Nasdaq GlobeNewswire

iCAD Announces Pricing of $22.0 Million Public Offering of Common Stock

03 3 2021 00:47:48 提供 Nasdaq GlobeNewswire

iCAD Announces Proposed Public Offering of Common Stock

02 3 2021 16:01:00 提供 Nasdaq GlobeNewswire

iCAD Reports Financial Results for Fourth Quarter and Year Ended December 31, 2020

24 2 2021 16:01:01 提供 Nasdaq GlobeNewswire

iCAD to Report Fourth Quarter 2020 Financial Results on Wednesday, February 24

18 2 2021 18:56:26 提供 Nasdaq GlobeNewswire

iCAD to Participate in the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference

16 2 2021 16:01:00 提供 Nasdaq GlobeNewswire

iCAD to Participate in B. Riley Securities Virtual Oncology Investor Conference

19 1 2021 08:00:02 提供 Nasdaq GlobeNewswire

iCAD to Participate in the LifeSci Partners 10th Annual Healthcare Corporate Access Event

06 1 2021 16:01:00 提供 Nasdaq GlobeNewswire